To better stratify patients who might be at risk for complications, numerous studies identified biological markers of worse prognosis, such as lymphopenia, and inflammatory markers such as C-reactive protein (CRP), lactate dehydrogenase (LDH), and cytokine levels (3, 10–15). The gene discussed is CRP; the disease is lymphopenia.